Review article: the management of hepatocellular carcinoma.
about
Combination of three-dimensional conformal radiotherapy and transcatheter arterial chemoembolisation versus transcatheter arterial chemoembolisation for primary hepatocellular carcinomaHepatocellular Carcinoma: Risk Factors, Diagnosis and TreatmentHypoxia-inducible factors as molecular targets for liver diseasesBiomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and chinaNrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinomaNatural borneol, a monoterpenoid compound, potentiates selenocystine-induced apoptosis in human hepatocellular carcinoma cells by enhancement of cellular uptake and activation of ROS-mediated DNA damageManagement strategies for hepatocellular carcinoma: old certainties and new realities.A new Child-Turcotte-Pugh class 0 for patients with hepatocellular carcinoma: determinants, prognostic impact and ability to improve the current staging systemsInduction of apoptosis and proliferation inhibition of hepatocellular carcinoma by 6-chloro-2-methoxy-N-(phenylmethyl)-9-acridinamine (BA): in vitro and vivo studies.Anticancer effects of imperatorin isolated from Angelica dahurica: induction of apoptosis in HepG2 cells through both death-receptor- and mitochondria-mediated pathways.Role of MicroRNAs in Hepatocellular CarcinomaEthanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm.Hepatocellular carcinoma in a large medical center of China over a 10-year period: evolving therapeutic option and improving survival.Determinants and outcomes of adherence to recommendations from a multidisciplinary tumour conference for hepatocellular carcinomaHypoxia inducible factor in hepatocellular carcinoma: A therapeutic targetSorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control studyQuality of life and its associated factors in patients with hepatocellular carcinoma receiving one course of transarterial chemoembolization treatment: a longitudinal study.Reactivation of tuberculosis in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: A report of 3 cases.The effects of sorafenib on liver regeneration in a model of partial hepatectomy.Sorafenib and hepatic arterial infusion chemotherapy for unresectable advanced hepatocellular carcinoma: A comparative studyAlpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.MRI-monitored transcatheter intra-arterial delivery of SPIO-labeled natural killer cells to hepatocellular carcinoma: preclinical studies in a rodent model.Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma.Multidisciplinary management of hepatocellular carcinoma: a model for therapy.The anti-viral effect of sorafenib in hepatitis C-related hepatocellular carcinomaUnresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteriaDelayed Diagnosis of HCC with Chronic Alcoholic Liver Disease.Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B.The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinomaRole of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma.The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011.Systematic review: the role of liver transplantation in the management of hepatocellular carcinoma.Targeted therapies in the treatment of advanced hepatocellular carcinomaTreatment of hepatocellular carcinoma: a systematic review.Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose.Interventional treatment for unresectable hepatocellular carcinoma.Sorafenib-induced liver failure: a case report and review of the literature.Small hepatocellular carcinoma: current and future approaches.Interventional radiology and the care of the oncology patient.On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study.
P2860
Q26471711-4E4B448A-66BF-4908-B49E-B36A30A601D1Q26747551-A113DB71-A1A2-4F98-9140-6D321F0F74FAQ26752304-8E397C07-9EF5-4C26-B64A-12C6232A1998Q27003291-35B61A01-228A-4196-8C98-5461ACBE57F8Q28383853-FC53408A-6A4E-455C-A086-2BC2D9C86FA8Q28488280-59CF6AB0-0A83-4B76-8C06-FAF87454151FQ30252143-944F897D-B567-47B5-B6FD-F6285E99BBF8Q33721747-3E01FDE9-97A3-4D3B-8D56-DC295AFFDDA6Q33868747-4C7D7AE7-4DD7-4009-B24D-82F452D1E770Q34108042-F9F03351-4E64-4FEA-962D-0D5D10FEA577Q34348824-8B83A375-8E69-4E7A-AD87-85447088F95AQ35171592-21C30558-A684-4E12-96F9-578424B2B15EQ35552046-557E7E27-AD78-4B9B-A81F-94B7FC769363Q35805862-DF771197-9DB7-4D75-9D50-AA63D1786D45Q35843846-5E60819F-DDF0-4375-A8AB-B80077A1D57AQ35984385-87CDB918-B805-412B-A82F-0D0B4712623FQ35989999-F943D42D-9997-4982-B70F-58321FB1F9C8Q36067422-8E180CCE-F63F-4703-8C6F-05720CB4509EQ36166298-9F7C400D-D0DE-4D00-86CB-D2620F60970BQ36230740-CA58D38E-B939-4217-8432-ED6D030BAB71Q36782253-98C10FDA-F357-45F0-A3FF-7516F934FE8EQ36816202-0BF544F6-6C43-4805-88B9-B392D95389C3Q36840196-1FABAEB6-C570-47ED-86A0-D1B62D70B8D0Q36851992-F2EF70D6-774C-4F0F-A951-77F275E2422CQ36929326-3631A8DB-1EB3-4B4F-8CF8-2DD9BCA427F5Q37039550-C0096EA5-BC88-4EE4-BA8B-9E17E9089846Q37140682-5622483E-9CC4-410A-AE03-C2CB48FBEAD1Q37226421-41311DA0-F8D2-4389-985C-50AA48748436Q37253389-5B299199-8941-4D39-8E81-3450F5435913Q37989160-29057AED-69DD-4D6B-8D37-646ECBFEE69CQ37995237-A7D33726-F330-4162-A51E-E694593E68D1Q37995306-A7FEB36F-9714-42FE-84F3-C33A41B2E444Q38114062-DC1D5FA6-7039-4F62-A4B0-362CBD6E43D9Q38155508-BEBDD04F-AAF5-4183-B600-D391586A6DF5Q38213800-26650F18-BFEE-4E0B-B961-9CAF5D6E507FQ38259537-83E010D6-9A9B-4177-8547-A1B00D94C527Q38466916-ABF36EE1-2C75-4ACD-BE0D-53976E60895BQ38552269-08AA71C0-B7BA-4DFD-B0FE-CE6C1A034AF9Q38757170-EBCB5CD9-55CB-4CD4-A727-0D6E605A9AD7Q38933901-76D1ACAA-E4B3-4E6C-BA39-B69F18CD8C4D
P2860
Review article: the management of hepatocellular carcinoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Review article: the management of hepatocellular carcinoma.
@en
Review article: the management of hepatocellular carcinoma.
@nl
type
label
Review article: the management of hepatocellular carcinoma.
@en
Review article: the management of hepatocellular carcinoma.
@nl
prefLabel
Review article: the management of hepatocellular carcinoma.
@en
Review article: the management of hepatocellular carcinoma.
@nl
P2860
P1476
Review article: the management of hepatocellular carcinoma.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2036.2009.04200.X
P407
P577
2009-11-19T00:00:00Z